Lehrstuhl für Haut- und Geschlechtskrankheiten

Address:
Hartmannstraße 14
91052 Erlangen



Subordinate Organisational Units

Professur für Dermatologie
Professur für Dermatologie und Venerologie - Reallocation / Closing
Professur für die Biologie Dendritischer Zellen
Professur für Experimentelle Dermatologie
Professur für Strategien der zellulären Immuntherapie
Professur für Tumorimmunologie (Schwerpunkt Systembiologie)


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 6 Go to next page Go to last page

Lee, J.-H., Dindorf, J., Eberhardt, M., Lai, X., Ostalecki, C., Koliha, N.,... Baur, A. (2019). Innate extracellular vesicles from melanoma patients suppress beta-catenin in tumor cells by miRNA-34a. Life Science Alliance, 2(2). https://dx.doi.org/10.26508/lsa.201800205
Krueckel, A., Moreira, A., Froehlich, W., Schuler, G., & Heinzerling, L. (2019). Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5384-z
Moreira, A., Gross, S., Kirchberger, M.C., Erdmann, M., Schuler, G., & Heinzerling, L. (2019). Senescence markers: Predictive for response to checkpoint inhibitors. International Journal of Cancer, 144(5), 1147-1150. https://dx.doi.org/10.1002/ijc.31763
Riethdorf, S., Hildebrandt, L., Heinzerling, L., Heitzer, E., Fischer, N., Bergmann, S.,... Pantel, K. (2019). Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clinical Chemistry, 65(3), 462-472. https://dx.doi.org/10.1373/clinchem.2018.297028
Simon, B., Wiesinger, M., Maerz, J., Wistuba-Hamprecht, K., Weide, B., Schuler-Thurner, B.,... Uslu, U. (2019). The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy. In EXPERIMENTAL DERMATOLOGY (pp. E56-E57). HOBOKEN: WILEY.
Boscheinen, J., Thomann, S., Knipe, D.M., Deluca, N., Schuler-Thurner, B., Gross, S.,... Schuster, P. (2019). Generation of an oncolytic herpes simplex virus 1 expressing human MelanA. Frontiers in Immunology, 10(JAN). https://dx.doi.org/10.3389/fimmu.2019.00002
Moreira, A., Loquai, C., Pfoefer, C., Kaehler, K.C., Knauss, S., Heppt, M.V.,... Heinzerling, L. (2019). Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European journal of cancer, 106, 12-23. https://dx.doi.org/10.1016/j.ejca.2018.09.033
Heger, L., Heidkamp, G., Lehmann, C., Söder, S., Hartmann, A., Alexiou, C.,... Dudziak, D. (2018). Comparative analysis of human dendritic cell subpopulations in steady state and inflammation. (pp. 156-156).
Baur, A., Lee, J.H., Eberhardt, M., Blume, K., Schuler, G., & Vera González, J. (2018). Tumor-suppressing Plasma extracellular Vesicles (pEV) from Melanoma Patients are secreted by Liver Cells and PBMC. (pp. 26-26).
Simon, B., Wiesinger, M., Marz, J., Wistuba-Hamprecht, K., Weide, B., Schuler-Thurner, B.,... Uslu, U. (2018). The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma. (pp. 8-8).
Moreira, A., Loquai, C., Knauss, S., Gutzmer, R., Dimitriou, F., Meier, F.,... Heinzerling, L. (2018). Neuromuscular Side Effects of Immune Checkpoint Inhibitors. (pp. 9-10).
Rossner, S., Czerwinski, T., Mark, C., Gross, S., Karg, M., Bosch, J.,... Bosch-Voskens, C. (2018). Ex vivo expanded NK Cells from Melanoma Patients receive their Migration in a 3D Model and lyse autologous Melanoma Cells. (pp. 52-52).
Baur, A., Lee, J.H., Dindorf, J., Eberhardt, M., Lai, X., Ostalecki, C.,... Vera González, J. (2018). Extracellular Vesicles in the Plasma of Melanoma Patients under-press beta Catenin in Tumor Cells by using miRNA-34a. (pp. 26-26).
Toussaint, F., Erdmann, M., Moreira, A., Kirchberger, M.C., Schuler, G., & Heinzerling, L. (2018). Eosinophilic Fasciitis by Treatment with Checkpoint Inhibitors in metastatic Melanoma. (pp. 76-76).
Moreira, A., Gross, S., Kirchberger, M.C., Erdmann, M., Schuler, G., & Heinzerling, L. (2018). Expression of Senescence Markers - Is Predictive for Immune Therapy with Checkpoint Inhibitors? (pp. 75-75).
Kirchberger, M.C., Ugurel, S., Mangana, J., Heppt, M., Eigentler, T., Berking, C.,... Heinzerling, L. (2018). FV03 MEK Inhibitors improved the Survival of NRAS-mutated Melanoma Patients by using Checkpoint Inhibitors: Results of a retrospective, multicenter Analysis of 364 Patients. (pp. 4-4).
Sirtl, S., Knoll, G., Dieu Thuy Trinh, ., Lang, I., Siegmund, D., Gross, S.,... Ehrenschwender, M. (2018). Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors. Oncogene, 37(30), 4122-4136. https://dx.doi.org/10.1038/s41388-018-0265-5
Kirchberger, M.C., Schilling, B., Haferkamp, S., Boßerhoff, A.K., Schuler, G., & Heinzerling, L. (2018). Can checkpoint inhibitor therapy improve response to chemotherapy? Journal of Cancer Research and Clinical Oncology, 144(1), 183-185. https://dx.doi.org/10.1007/s00432-017-2546-8
Simon, B., Wiesinger, M., Maerz, J., Wistuba-Hamprecht, K., Weide, B., Schuler-Thurner, B.,... Uslu, U. (2018). The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma. International Journal of Molecular Sciences, 19(8). https://dx.doi.org/10.3390/ijms19082365
Simon, B., Harrer, D., Schuler-Thurner, B., Dörrie, J., Schaft, N., Schuler, G., & Uslu, U. (2018). The simultaneous siRNA-mediated downregulation of PD-1 and CTLA-4 to improve CAR-T cell immunotherapy of melanoma. (pp. E52-E53).


Publications in addition (Download BibTeX)


Koeceroglu, I., Bosch-Voskens, C., & Erdmann, M. (2019). Dyspnoea under Immunotherapy for Patients with Melanoma: Pneumonia, Pulmonary Embolism, Pneumonitis or Myocarditis? In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 148-149). HOBOKEN: WILEY.
Weller, K., Maurer, M., Bauer, A., Wedi, B., Wagner, N., Schliemann, S.,... Staubach, P. (2019). Psychiatric disorders are common comorbidities in patients with chronic spontaneous or inducible urticaria in Germany. In JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (pp. 115-115). HOBOKEN: WILEY.
Wagner, N., & Podda, M. (2018). High volume of polysorbate-containing (Tween® 80) solutions induces false-positive results in intradermal test. Journal of the European Academy of Dermatology and Venereology, 32(11), 1972-1976. https://dx.doi.org/10.1111/jdv.14999

Last updated on 2019-24-04 at 10:30